FDA Import Refusal 110-3898893-6/14/1 — Xellia Pharmaceuticals ApS
The FDA refused shipment 110-3898893-6/14/1 from Xellia Pharmaceuticals ApS (Denmark) on July 29, 2002. The refused product falls under Drugs and Biologics — COLISTIN SULFATE (PEPTIDES). Cited charge: 16 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- July 29, 2002
- Country
- Denmark
- Product Category
- Drugs and Biologics
- Product Code
- 56FCS21 COLISTIN SULFATE (PEPTIDES)
- Charges
- 16